Since their first description five years ago, knowledge about human at
rial 5-NT4 receptors has increased considerably. Progress has been fac
ilitated by the advent of selective antagonists with high affinity for
human atrial 5-HT4 receptors. The receptors have been detected in bot
h right and left atrium where they mediate increases in contractile fo
rce. Human sinoatrial 5-HT4 receptors may mediate the tachycardia caus
ed by 5-HT and cisapride, and 5-HT elicits arrhythmias via 5-HT4 recep
tors in human atrium. In this article, Alberto Kaumann suggests that 5
-HT may be involved in the genesis of atrial fibrillation acid associa
ted thromboembolic stroke and that both the arrhythmia and stroke coul
d be prevented by inhibiting 5-HT4 receptors.